FibroBiologics, Inc. Common Stock

FibroBiologics, Inc. Common Stockverified

FBLG

Price:

$0.26

Market Cap:

$10.90M

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Industry

Biotechnology

IPO Date

2024-02-01

Stock Exchange

NASDAQ

Ticker

FBLG

The PE Ratio as of December 2025 (TTM) for FibroBiologics, Inc. Common Stock (FBLG) is -0.54

According to FibroBiologics, Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -0.54. This represents a change of -96.40% compared to the average of -15.01 of the last 4 quarters.

FibroBiologics, Inc. Common Stock (FBLG) Historical PE Ratio (quarterly & annually)

How has FBLG PE Ratio performed in the past?

The mean historical PE Ratio of FibroBiologics, Inc. Common Stock over the last ten years is -330.88. The current -0.54 PE Ratio has changed -83.68% with respect to the historical average. Over the past ten years (40 quarters), FBLG's PE Ratio was at its highest in in the June 2024 quarter at 36.44. The PE Ratio was at its lowest in in the March 2022 quarter at -201.84.

Quarterly (TTM)
Annual

Average

-330.88

Median

-184.64

Minimum

-808.83

Maximum

-5.89

FibroBiologics, Inc. Common Stock (FBLG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of FibroBiologics, Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -5.89

Minimum Annual Increase = -89.73%

Minimum Annual PE Ratio = -808.83

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.89-89.73%
2023-57.36-68.94%
2022-184.64-69.11%
2021-597.67-26.11%

FibroBiologics, Inc. Common Stock (FBLG) Average PE Ratio

How has FBLG PE Ratio performed in the past?

The current PE Ratio of FibroBiologics, Inc. Common Stock (FBLG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-82.63

5-year avg

-330.88

10-year avg

-330.88

FibroBiologics, Inc. Common Stock (FBLG) PE Ratio vs. Peers

How is FBLG’s PE Ratio compared to its peers?

FibroBiologics, Inc. Common Stock’s PE Ratio is greater than Daré Bioscience, Inc. (-1.31), less than Athira Pharma, Inc. (-0.41), less than Aditxt, Inc. (-0.00), greater than Ainos, Inc. (-0.76), less than Citius Pharmaceuticals, Inc. (-0.34), less than Moleculin Biotech, Inc. (-0.28), greater than Leap Therapeutics, Inc. (-0.80), less than Apollomics, Inc. (-0.30), greater than SeaStar Medical Holding Corporation (-0.69), greater than Hoth Therapeutics, Inc. (-1.54),

Build a custom stock screener for FibroBiologics, Inc. Common Stock (FBLG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FibroBiologics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

FibroBiologics, Inc. Common Stock (FBLG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like FibroBiologics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is FibroBiologics, Inc. Common Stock's PE Ratio?

How is the PE Ratio calculated for FibroBiologics, Inc. Common Stock (FBLG)?

What is the highest PE Ratio for FibroBiologics, Inc. Common Stock (FBLG)?

What is the 3-year average PE Ratio for FibroBiologics, Inc. Common Stock (FBLG)?

What is the 5-year average PE Ratio for FibroBiologics, Inc. Common Stock (FBLG)?

How does the current PE Ratio for FibroBiologics, Inc. Common Stock (FBLG) compare to its historical average?